Beta‐blockers for hypertension
140 results
61 - 140
Elevated blood pressure in pregnancy (gestational hypertension, pre-eclampsia) 
Band ligation versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis- Calcium channel blockers versus other classes of drugs for hypertension
- Follow-up of type 1 diabetes
- Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion‐dependent beta thalassaemia
- Effect of antihypertensive drugs on mortality, morbidity and blood pressure in blacks: Cochrane systematic review
- Medical interventions for primary open angle glaucoma and ocular hypertension
- Pharmacotherapy for hypertension in the elderly
- Sclerotherapy versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis
- Adverse effects of hypertension treatment during pregnancy
- Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
- First‐line diuretics versus other classes of antihypertensive drugs for hypertension
- Calcium channel blockers versus other classes of drugs for hypertension
- Different antihypertensive agents as first line therapies
- Pharmacological interventions for hypertension in children
- Beta‐blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
- First‐line drugs for hypertension
- First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension: Cochrane systematic review
- Carvedilol versus traditional, non‐selective beta‐blockers for adults with cirrhosis and gastroesophageal varices
- Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension: Cochrane systematic review
- Chronic diseases and pregnancy
- Metabolic syndrome
- Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices
- Treatment of hypertension in peripheral arterial disease
- Choice of antihypertensive drug in the diabetic patient from prognostic point of view
- Antihypertensive drugs and incident diabetes
- Chronic heart failure
Beta-blockers associated with improved morbidity/mortality in COPD patients- Erectile dysfunction
- Chronic coronary syndrome (coronary heart disease)
- Lowering blood pressure does not decrease the risk of T2DM in persons with hypertension; ACEIs/ARBs do
- Hypertension in elderly patients
- Prevention of atrial fibrillation
- Exercise stress test
- Antihypertensive therapy beneficial for patients with BP < 140/90 and history of CVD
- Choice of prophylactic medication for atrial fibrillation - Image
- JNC 8 report on prevention/evaluation/treatment of hypertension
- Medical treatment of glaucoma and intraocular hypertension
- Diabetic kidney disease (diabetic nephropathy)
- Pharmacotherapy for hypertension in adults aged 18 to 59 years
- Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension: Cochrane systematic review
- Acute coronary syndrome
- Hypertension: investigations, treatment initiation and non-pharmacological treatment
- COVID-19 research briefs: Antihypertensive use not associated with an increased risk of SARS-CoV-2 infection
- Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals
- Interventions for preventing and managing advanced liver disease in cystic fibrosis
- Band ligation versus sclerotherapy for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
- ACC/AHA guidelines for atrial fibrillation
- Primary hyperaldosteronism (PHA)
- Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis
- Raynaud's phenomenon (RP) or white finger disease
- Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis
- BP lowering by any means is beneficial in most
- The most common types of acquired adult valvular heart disease and associated murmurs
- Aortic stenosis
- Identification of illegal drug overdose and diagnosis of illegal drug poisoning
- Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
- Platelet count, spleen length, and platelet count‐to‐spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis
- Treatment of chronic renal failure
- Interventions for fatigue in people with kidney failure requiring dialysis
- Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews
- Use of medication during pregnancy